NextCure, Inc. Research And Development Expense

• NextCure, Inc. showed an increase of +8.3% in Research And Development Expense from 2024 to 2025.
• This data is from NextCure, Inc.'s annual report (Form 10-K), filed with the SEC on March 5, 2026.
• XBRL data for this metric is available from 2018 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 8 years of available data (2018 to 2025), NextCure, Inc.'s Research And Development Expense has grown by 127.0%.
• Historical annual values: Fiscal year 2025: $44.92 million | Fiscal year 2024: $41.49 million | Fiscal year 2023: $47.93 million | Fiscal year 2022: $54.20 million | Fiscal year 2021: $50.19 million | Fiscal year 2020: $46.55 million | Fiscal year 2019: $34.22 million | Fiscal year 2018: $19.79 million.
• Data sourced from SEC EDGAR public filings as of June 20, 2026.

Last verified: June 20, 2026